Skip to main content
OpenTrials

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,640 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms

NCT00002357

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • Stanford Univ School of Medicine Stanford, California, United States
  • Georgetown Univ Med Ctr Washington D.C., District of Columbia, United States
  • Med College of Georgia Augusta, Georgia, United States
View Trial Details
Completed

A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients

NCT00002236

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • AIDS Healthcare Foundation Los Angeles, California, United States
  • UCSF AIDS Research Institute San Francisco, California, United States
  • Saint Luke's - Roosevelt Hosp Ctr New York, United States
  • Anderson Clinical Research Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

A Study of PMPA in HIV-Infected Patients

NCT00002180

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • San Francisco Gen Hosp / AIDS Program San Francisco, California, United States
  • Johns Hopkins Univ Baltimore, Maryland, United States
View Trial Details
Completed

A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection

NCT00002117

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Kaiser Foundation Hosp Harbor City, California, United States
  • Kaiser Permanente Med Ctr Los Angeles, California, United States
  • Sharp Rees - Stealy Med Group San Diego, California, United States
  • UCSF - San Francisco Gen Hosp San Francisco, California, United States
View all 24 locations
View Trial Details
Completed

Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection

NCT00002441

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Body Positive Phoenix, Arizona, United States
  • Arizona Clinical Research Ctr Inc Tucson, Arizona, United States
  • Univ of California / UCI Med Ctr Orange, California, United States
View all 67 locations
View Trial Details
Completed

The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected Children

NCT00000843

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UCSF / Moffitt Hosp - Pediatric San Francisco, California, United States
  • Univ of Florida Health Science Ctr / Pediatrics Jacksonville, Florida, United States
  • Chicago Children's Memorial Hosp Chicago, Illinois, United States
  • Johns Hopkins Hosp - Pediatric Baltimore, Maryland, United States
View Trial Details
Completed

A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.

NCT00002126

Conditions
Acquired Immunodeficiency Syndrome, Agranulocytosis, Blood-Borne Infections, +21 more
Locations
  • Univ of Alabama at Birmingham / AIDS Outpatient Clinic Birmingham, Alabama, United States
  • Maricopa County Med Ctr Phoenix, Arizona, United States
  • CARE Ctr / UCLA Med Ctr Los Angeles, California, United States
  • UCSF - San Francisco Gen Hosp San Francisco, California, United States
View all 22 locations
View Trial Details
Completed

A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3

NCT00002185

Conditions
AIDS-Related Opportunistic Infections, Blood-Borne Infections, Communicable Diseases, +25 more
Locations
  • LAC and USC Med Ctr / School of Medicine Los Angeles, California, United States
  • Univ of California / UCI Med Ctr Orange, California, United States
  • UCSD Treatment Ctr San Diego, California, United States
  • Santa Clara Valley Med Ctr San Jose, California, United States
View Trial Details
Completed

A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients

NCT00002151

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Clinical Investigations Health Services Mobile, Alabama, United States
  • California Clinical Trials Med Group Beverly Hills, California, United States
  • Southwest Community Based AIDS Treatment Group - COMBAT Los Angeles, California, United States
  • UCSF - San Francisco Gen Hosp San Francisco, California, United States
View all 24 locations
View Trial Details

Related conditions